Outlook Therapeutics Inc (NASDAQ: OTLK) kicked off on Friday, down -58.23% from the previous trading day, before settling in for the closing price of $1.58. Over the past 52 weeks, OTLK has traded in a range of $0.79-$3.39.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 33.18%. While this was happening, its average annual earnings per share was recorded 51.68%. With a float of $41.98 million, this company’s outstanding shares have now reached $43.48 million.
Outlook Therapeutics Inc (OTLK) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Outlook Therapeutics Inc is 34.52%, while institutional ownership is 6.31%.
Outlook Therapeutics Inc (OTLK) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.89 earnings per share (EPS), lower than consensus estimate (set at -0.75) by -0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.29% during the next five years compared to 33.18% growth over the previous five years of trading.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Take a look at Outlook Therapeutics Inc’s (OTLK) current performance indicators. Last quarter, stock had a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
As of the previous 9 days, the stock’s Stochastic %D was 5.97%.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 2.00%, which indicates a significant decrease from 2.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2464 in the past 14 days, which was higher than the 0.1746 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6809, while its 200-day Moving Average is $1.6249. Nevertheless, the first resistance level for the watch stands at $0.7186 in the near term. At $0.7771, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8343. If the price goes on to break the first support level at $0.6029, it is likely to go to the next support level at $0.5457. Now, if the price goes above the second support level, the third support stands at $0.4872.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
The company with the Market Capitalisation of 42.32 million has total of 64,114K Shares Outstanding. Its annual sales at the moment are 1,410 K in contrast with the sum of -62,420 K annual income. Company’s last quarter sales were recorded 1,510 K and last quarter income was -20,150 K.
